1[1]John EM,Hopper JL,Beck JC,Knight JA,Neuhausen SL,Senie RT,Ziogas A,Andrulis LL,Anton-Culver H,Boyd N,Buys SS,Daly MB,O'Malley FP,Santella RM,Southey MC,Venne VL,Venter DJ,West DW,Whittemore AS,Seminara D.The Breast Cancer Family Registry.The Breast Cancer Family Registry:an infrastructure for cooperative multinational,interdisciplinary and translational studies of the genetic epidemiology of breast cancer.Breast Cancer Res 2004; 6:375-389
2[2]Sawaki M,Ito Y,Hashimoto D,Mizunuma N,Takahashi S,Horikoshi N,Tada K,Kasumi F,Akiyama F,Sakamoto G,Imai T,Nakao A,Hatake K.Paclitaxel administered weekly in patients with docetaxel-resistant metastatic breast cancer:a single-center study.Tumori 2004; 90:36-39
3[3]Vogl TJ,Mack MG,Balzer JO,Engelmann K,Straub R,Eichler K,Woitaschek D,Zangos S.Liver metastases:neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.Radiology 2003; 229:457-464
5[5]Elias D,Sideris L,Pocard M,Ouellet JF,Boige V,Lasser P,Pignon JP,Ducreux M.Results of R0 resection for colorectal liver metastases associated with extrahepatic disease.Ann Surg Oncol 2004; 11:274-280
6[6]Ellias D,Lasser PH,Montrucolli D,Bonvallot S,Spielmann M.Hepatectomy for liver metastases from breast cancer.Eur J Surg Oncol 1995; 21:510-513
7[7]Yoshimoto M,Sugitani I,Iwase T,Watanabe S,Kasumi F.Therapeutic efficacy of hepatectomy in the treatment of hepatic metastases from breast cancer.Nippon Geka Gakkai Zasshi 1995; 96:174-179
8[8]Pocard M,Pouillart P,Asselain B,Salmon R.Hepatic resection in metastatic breast cancer:results and prognostic factors.Eur J Surg Oncol 2000; 26:155-159
9[9]Mayordomo JI,Milla A,Morales S,Yubero A,Lorenzo A,Baena JM,Modolell A,Sanz J,Illarramendi J,Garcia MJ,Machengs I,Burrilo MA,Tres A.Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.Clin Breast Cancer 2004; 5:131-135
10[10]Roche A,Girish BV,de Baere T,Baudin E,Boige V,Elias D,Lasser P,Schlumberger M,Ducreux M.Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.Eur Radiol 2003; 13:136-140
